These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37872658)

  • 21. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
    Desai NR; Cornutt D
    Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal agents for current and forthcoming direct oral anticoagulants.
    van Es N; De Caterina R; Weitz JI
    Eur Heart J; 2023 May; 44(20):1795-1806. PubMed ID: 36988142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.
    Weitz JI
    Semin Respir Crit Care Med; 2017 Feb; 38(1):40-50. PubMed ID: 28208197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergent Bleeding in Patients Receiving Direct Oral Anticoagulants.
    Summers RL; Sterling SA
    Air Med J; 2016; 35(3):148-55. PubMed ID: 27255877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Severe Bleeding in Patients Treated With Oral Anticoagulants: Proceedings Monograph From the Emergency Medicine Cardiac Research and Education Group-International Multidisciplinary Severe Bleeding Consensus Panel October 20, 2018.
    Gibler WB; Racadio JM; Hirsch AL; Roat TW
    Crit Pathw Cardiol; 2019 Sep; 18(3):143-166. PubMed ID: 31348075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal agents for oral anticoagulant-associated major or life-threatening bleeding.
    Moia M; Squizzato A
    Intern Emerg Med; 2019 Nov; 14(8):1233-1239. PubMed ID: 31446606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.
    Crawley RM; Anderson RL
    Drugs; 2020 Sep; 80(13):1293-1308. PubMed ID: 32691292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of direct oral anticoagulants.
    Almegren M
    Vasc Health Risk Manag; 2017; 13():287-292. PubMed ID: 28769570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.
    Reilly PA; van Ryn J; Grottke O; Glund S; Stangier J
    Am J Med; 2016 Nov; 129(11S):S64-S72. PubMed ID: 27569674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs).
    Hussain SS; Tyroch AH; Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2017; 14(2):76-81. PubMed ID: 27215215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When and How to Use Reversal Agents for Direct Oral Anticoagulants?
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R
    Curr Cardiol Rep; 2023 May; 25(5):371-380. PubMed ID: 36976497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present Knowledge on Direct Oral Anticoagulant and Novel Oral Anti Coagulants and Their Specific Antidotes: A Comprehensive Review Article.
    Biswas S; Bahar Y; Bahar AR; Safiriyu I; Mathai SV; Hajra A; Gupta R; Aronow WS
    Curr Probl Cardiol; 2023 Feb; 48(2):101483. PubMed ID: 36336118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct oral anticoagulants toxicity in children: an overview and practical guide.
    Daei M; Abbasi G; Khalili H; Heidari Z
    Expert Opin Drug Saf; 2022 Sep; 21(9):1183-1192. PubMed ID: 35924671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing the perioperative patient on direct oral anticoagulants.
    Leitch J; van Vlymen J
    Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice.
    Heuts S; Ceulemans A; Kuiper GJAJM; Schreiber JU; van Varik BJ; Olie RH; Ten Cate H; Maessen JG; Milojevic M; Maesen B
    Eur J Cardiothorac Surg; 2023 Oct; 64(4):. PubMed ID: 37812245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the bleeding risks associated with DOACs.
    Drug Ther Bull; 2017 Nov; 55(11):129-132. PubMed ID: 29117993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of direct oral anticoagulant therapy reversal.
    Gulseth MP
    Am J Health Syst Pharm; 2016 May; 73(10 Suppl 2):S5-S13. PubMed ID: 27147458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.
    Benamouzig R; Guenoun M; Deutsch D; Fauchier L
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):973-989. PubMed ID: 34143317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.